Literature DB >> 16446474

The Canadian Diabetes Association guidelines: putting the evidence first.

Michael C Howlett1, Donna Lillie.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16446474      PMCID： PMC1373716          DOI： 10.1503/cmaj.051556

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  Clinical practice guidelines and conflict of interest.

Authors: 
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262
  1 in total
  2 in total

1.  Evidence and advocacy: are all things considered?

Authors:  Jeffrey A Johnson; Alun L Edwards
Journal:  CMAJ       Date:  2006-06-20       Impact factor: 8.262

2.  A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

Authors:  John W Newcomer; Robert E Ratner; Jan W Eriksson; Robin Emsley; Didier Meulien; Frank Miller; Julia Leonova-Edlund; Ronald W Leong; Martin Brecher
Journal:  J Clin Psychiatry       Date:  2009-04-07       Impact factor: 4.384
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.